Cannabidiol/Isoflurane

大麻二酚/异氟烷

Report date: 2025/04/25 15:08:14

Base Information

Drug NameCannabidiol/Isoflurane
Drug Alias NameIHL-216A
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsBrain ConcussionBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes CannabidiolIsoflurane
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIncannex Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIncannex Healthcare Ltd
Inactive CompaniesN/A
Active IndicationsBrain ConcussionBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A